Álvaro-Benito M, Morrison E, Ebner F, Abualrous ET, Urbicht M, Wieczorek M, et al. Distinct editing functions of natural HLA-DM allotypes impact antigen presentation and CD4+ T cell activation. Cell Mol Immunol. 2020;17:133–42.
Zeiser R, Teshima T. Nonclassical manifestations of acute GVHD. Blood. 2021;138:2165–72.
Article PubMed CAS Google Scholar
Velardi A, Mancusi A, Ruggeri L, Pierini A. How adoptive transfer of components of the donor immune system boosts GvL and prevents GvHD in HLA-haploidentical hematopoietic transplantation for acute leukemia. Bone Marrow Transpl. 2024;59:301–5.
Raiola AM, Risitano A, Sacchi N, Giannoni L, Signori A, Aquino S, et al. Impact of HLA disparity in haploidentical bone marrow transplantation followed by high-dose cyclophosphamide. Biol Blood Marrow Transpl. 2018;24:119–26.
de Almeida GP, Lichtner P, Eckstein G, Brinkschmidt T, Chu C-F, Sun S, et al. Human skin-resident host T cells can persist long term after allogeneic stem cell transplantation and maintain recirculation potential. Sci Immunol. 2022;7:eabe2634.
Galli E, Metafuni E, Giammarco S, Limongiello MA, Innocenti I, Autore F, et al. Triple post transplant cyclophosphamide (PTCY) based GVHD prophylaxis: HLA matched versus HLA haploidentical transplants. Bone Marrow Transpl. 2022;57:532–7.
Wang Y, Chang Y-J, Xu L-P, Liu K-Y, Liu D-H, Zhang X-H, et al. Who is the best donor for a related HLA haplotype-mismatched transplant? Blood. 2014;124:843–50.
Article PubMed CAS Google Scholar
Chang Y-J, Xu L-P, Wang Y, Zhang X-H, Chen H, Chen Y-H, et al. Controlled, randomized, open-label trial of risk-stratified corticosteroid prevention of acute graft-versus-host disease after haploidentical transplantation. J Clin Oncol. 2016;34:1855–63.
Article PubMed CAS Google Scholar
Kanakry CG, Fuchs EJ, Luznik L. Modern approaches to HLA-haploidentical blood or marrow transplantation. Nat Rev Clin Oncol. 2016;13:10–24.
Article PubMed CAS Google Scholar
Robinson TM, O’Donnell PV, Fuchs EJ, Luznik L. Haploidentical bone marrow and stem cell transplantation: experience with posttransplantation cyclophosphamide. Semin Hematol. 2016;53:90–7.
Article PubMed PubMed Central Google Scholar
Yu S, Huang F, Fan Z, Xuan L, Nie D, Xu Y, et al. Haploidentical versus HLA-matched sibling transplantation for refractory acute leukemia undergoing sequential intensified conditioning followed by DLI: an analysis from two prospective data. J Hematol Oncol. 2020;13:18.
Article PubMed PubMed Central CAS Google Scholar
Robin M, Porcher R, Ruggeri A, Blaise D, Wolschke C, Koster L, et al. HLA-Mismatched Donors in Patients with Myelodysplastic Syndrome: An EBMT Registry Analysis. Biol Blood Marrow Transpl. 2019;25:114–20.
Lv M, Guo H-D, Huang X-J. A perfect mismatch: haploidentical hematopoietic stem cell transplantation overtakes a bend. Cell Mol Immunol. 2023;20:978–80.
Article PubMed PubMed Central CAS Google Scholar
Huo M-R, Pei X-Y, Li D, Chang Y-J, Xu L-P, Zhang X-H, et al. Impact of HLA allele mismatch at HLA-A, -B, -C, -DRB1, and -DQB1 on outcomes in haploidentical stem cell transplantation. Bone Marrow Transpl. 2018;53:600–8.
Kasamon YL, Luznik L, Leffell MS, Kowalski J, Tsai H-L, Bolaños-Meade J, et al. Nonmyeloablative HLA-haploidentical bone marrow transplantation with high-dose posttransplantation cyclophosphamide: effect of HLA disparity on outcome. Biol Blood Marrow Transpl. 2010;16:482–9.
Dickinson AM, Norden J. Non-HLA genomics: does it have a role in predicting hematopoietic stem cell transplantation outcome? Int J Immunogenet. 2015;42:229–38.
Article PubMed CAS Google Scholar
Goussetis E, Varela I, Peristeri I, Kitra V, Spanou K, Moraloglou O, et al. Cytokine gene polymorphisms and graft-versus-host disease in children after matched sibling hematopoietic stem cell transplantation: a single-center experience. Cell Mol Immunol. 2011;8:276–80.
Article PubMed PubMed Central CAS Google Scholar
Cieri N, Hookeri N, Stromhaug K, Li L, Keating J, Díaz-Fernández P, et al. Systematic identification of minor histocompatibility antigens predicts outcomes of allogeneic hematopoietic cell transplantation. Nat Biotechnol. 2024. https://doi.org/10.1038/s41587-024-02348-3. Online ahead of print.
Martin PJ, Levine DM, Storer BE, Warren EH, Zheng X, Nelson SC, et al. Genome-wide minor histocompatibility matching as related to the risk of graft-versus-host disease. Blood. 2017;129:791–8.
Article PubMed PubMed Central CAS Google Scholar
Cantoni N, Hirsch HH, Khanna N, Gerull S, Buser A, Bucher C, et al. Evidence for a bidirectional relationship between cytomegalovirus replication and acute graft-versus-host disease. Biol Blood Marrow Transpl. 2010;16:1309–14.
Akahoshi Y, Kimura S-I, Tada Y, Matsukawa T, Tamaki M, Doki N, et al. Cytomegalovirus gastroenteritis in patients with acute graft-versus-host disease. Blood Adv. 2022;6:574–84.
Article PubMed PubMed Central CAS Google Scholar
Riesner K, Cordes S, Peczynski C, Kalupa M, Schwarz C, Shi Y, et al. Reduced calcium signaling is associated with severe graft-versus-host disease: results from preclinical models and from a prospective EBMT Study. Front Immunol. 2020;11:1983.
Article PubMed PubMed Central CAS Google Scholar
Ogasawara R, Hashimoto D, Kimura S, Hayase E, Ara T, Takahashi S, et al. Intestinal lymphatic endothelial cells produce R-Spondin3. Sci Rep. 2018;8:10719.
Article PubMed PubMed Central Google Scholar
Hayase E, Hashimoto D, Nakamura K, Noizat C, Ogasawara R, Takahashi S, et al. R-Spondin1 expands Paneth cells and prevents dysbiosis induced by graft-versus-host disease. J Exp Med. 2017;214:3507–18.
Article PubMed PubMed Central CAS Google Scholar
Lu C, Ma H, Song L, Wang H, Wang L, Li S, et al. IFN-γR/STAT1 signaling in recipient hematopoietic antigen-presenting cells suppresses graft-versus-host disease. J Clin Invest. 2023;133:e125986.
Article PubMed PubMed Central CAS Google Scholar
Zhang Y, Shen L, Dreißigacker K, Zhu H, Trinh-Minh T, Meng X, et al. Targeting of canonical WNT signaling ameliorates experimental sclerodermatous chronic graft-versus-host disease. Blood. 2021;137:2403–16.
Article PubMed CAS Google Scholar
Rakotomamonjy A. Variable selection using SVM based criteria. J Mach Learn Res. 2003;3:1357–70.
Liu QZ, Chen CH, Zhang Y, Hu ZG. Feature selection for support vector machines with RBF kernel. Artif Intell Rev. 2011;36:99–115.
Zhao JQ, Karimzadeh M, Masjedi A, Wang TJ, Zhang XW, Crawford MM, et al. FeatureExplorer: Interactive Feature Selection and Exploration of Regression Models for Hyperspectral Images. 2019 IEEE Visualization Conference (Vis). 2019:161–5.
Ciurea SO. Considerations for haploidentical versus unrelated donor transplants. Bone Marrow Transpl. 2019;54:738–42.
Sanz J, Labopin M, Choi G, Kulagin A, Peccatori J, Vydra J, et al. Younger unrelated donors may be preferable over HLA match in the PTCy era: a study from the ALWP of the EBMT. Blood. 2024;143:2534–43.
Article PubMed CAS Google Scholar
Sato-Otsubo A, Nannya Y, Kashiwase K, Onizuka M, Azuma F, Akatsuka Y, et al. Genome-wide surveillance of mismatched alleles for graft-versus-host disease in stem cell transplantation. Blood. 2015;126:2752–63.
Article PubMed CAS Google Scholar
Harkensee C, Oka A, Onizuka M, Middleton PG, Inoko H, Hirayasu K, et al. Single nucleotide polymorphisms and outcome risk in unrelated mismatched hematopoietic stem cell transplantation: an exploration study. Blood. 2012;119:6365–72.
Article PubMed CAS Google Scholar
Wang W, Huang H, Halagan M, Vierra-Green C, Heuer M, Brelsford JE, et al. Chr
Comments (0)